Bronchitis
📧 Sign up to get email alerts when something new happens for Bronchitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Copeptin: Disease Severity Indicator [NA]
A completed clinical trial evaluated copeptin as a biomarker for disease severity in patients with lower respiratory tract infections, inclu…
-
FDA approval · 2024-05-21FDA Approved: THEOPHYLLINE — Original Application (Zydus Lifesciences Limited)
FDA approved an original ANDA for Theophylline by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes [Phase 2]
Phase 2 trial update assessing pulmonary and cardiac effects of e-cigarette use in smokers with pulmonary disease; the study has completed r…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 study evaluating the safety and efficacy of ivacaftor in chronic obstructive …
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule [Phase 4]
Phase 4 trial evaluating efficacy and safety of Bronpass Tab versus Erdos Capsule for acute bronchitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis Inc.)
FDA approved a generic Amoxicillin and clavulanate potassium product under Original Application by Devatis Inc.
-
FDA approval · 2023-06-06FDA Approved: ROFLUMILAST — Supplemental Application (Solco Healthcare US, LLC.)
The FDA approved a supplemental application for a generic roflumilast product from Solco Healthcare US, LLC. This approval makes a generic C…
-
FDA approval · 2023-03-20FDA Approved: THEOPHYLLINE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's Theophylline (generic) under an Original Application (ANDA 216276). Theophylline is indicated for relief of bronchospa…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB) [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of ION-827359 in mild to moderate COPD with chronic bronchitis; study terminated …
-
FDA approval · 2022-11-02FDA Approved: AMOXICILLIN — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for Amoxicillin submitted by USAntibiotics, LLC.
-
FDA label_change · 2022-09-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for amoxicillin and clavulanate potassium submitted by Northstar RxLLC, resulting in updated labelin…
-
CLINICAL_TRIALS research · 2022-08-30Clinical Trial Update: Effectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Acute Bronchitis. [Phase 4]
Phase 4 trial evaluating the effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with acute bronchitis.
-
FDA approval · 2022-05-10FDA Approved: ROFLUMILAST — Original Application (Solco Healthcare US, LLC.)
FDA approved the original ANDA for roflumilast by Solco Healthcare US, LLC, authorizing a generic version of the COPD medication.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Gala Early Feasibility Study of RheOx [NA]
An early feasibility study update for RheOx by Gala Therapeutics; current status and results posted in 2022 with indications including chron…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis [Phase 3]
A Phase 3 clinical trial evaluating AG1904 for safety and efficacy in acute bronchitis has completed.
-
CLINICAL_TRIALS withdrawal · 2022-02-17Clinical Trial Update: VX-770 for the Treatment of Chronic Bronchitis [Phase 4]
A Phase 4 clinical trial evaluating VX-770 for chronic bronchitis was withdrawn.
-
FDA approval · 2022-01-12FDA Approved: AZITHROMYCIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for AZITHROMYCIN submitted by Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Effect of BIBW 2948 BS in COPD [Phase 2]
Phase 2 trial results for BIBW 2948 BS in chronic obstructive pulmonary disease and chronic bronchitis have been completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD [Phase 4]
A Phase 4 trial update assesses immunogenicity, safety of a third BBIBP-CorV dose, and immune persistence in elderly individuals with chroni…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of an inactivated COVID-19 vaccine in elderly individuals with chronic bronchitis …
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of an inactivated COVID-19 vaccine in patients aged 60 and older with chronic bron…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng) [Phase 4]
Phase 4 clinical trial update evaluating Zhuli Capsule for phlegm-heat syndrome in chronic obstructive pulmonary disease and chronic bronchi…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: NBMI - Clinical Study on COPD [Phase 2]
Phase 2 clinical trial update for NBMI in chronic obstructive pulmonary disease and COPD bronchitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD [NA]
A completed clinical trial assessing the impact of physical activity promotion on short- and long-term outcomes in COPD.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Efficacy and Safety Evaluation in Recurrent Wheezing Attacks [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety for recurrent wheezing attacks; results completed and posted in 2020.